CCC announced today in a press release the availability of AI-disambiguated data and enriched metadata, for researchers and institutions, within RightFind Navigate through a pilot for its customers. CCC also announced several powerful new features of the RightFind Suite.
Pharmaceutical and life science companies are dealing with tremendous growth in available information and an increasingly diverse range of sources that make it challenging to maintain a comprehensive and up-to-date understanding on key research advancements. RightFind Navigate’s machine-learning driven semantic enrichment and advanced personalization features help users locate the most relevant information in scientific literature, clinical trials, patents, and many other sources. This pilot expands the data intelligence already available in RightFind Navigate with the introduction of disambiguated researcher and institution profiles.
RightFind Navigate is part of the RightFind Suite, which provides a single integrated and scalable solution to meet the evolving needs of today’s research organizations. RightFind Navigate unifies searching across multiple licensed content sources, publicly available data, and internal proprietary content, empowering researchers to reveal connections and drive innovation. The solution provides a flexible, scalable, open ecosystem designed to maximize an organizations’ return on their content and data investments.
“Many of our RightFind customers already enjoy the benefits of semantic search and the breadth of information sources that are available in RightFind Navigate,” said Tracey Armstrong, President and CEO, CCC. “We are excited to pilot the introduction of research and institution profiles that allow users to see the web of connections between the various entities engaged in a particular research field, whether these are researchers in corporations or in academia, and with whom they are affiliated.”